Best Biotech Stocks to Buy Now (2024)Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.
Industry: Biotechnology
| Ticker | Company | Forecast Score | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| INCY | INCYTE CORP | $11.86B | $52.82 | $73.92 | 39.94% | Buy | 12 | 11.49% | 52.77% | N/A | N/A | ||||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.65B | $29.03 | $37.33 | 28.60% | Buy | 6 | 17.13% | 42.05% | N/A | N/A | ||||
| VYGR | VOYAGER THERAPEUTICS INC | $409.97M | $7.55 | $20.50 | 171.52% | Strong Buy | 4 | -25.11% | N/A | N/A | N/A | ||||
| AMLX | AMYLYX PHARMACEUTICALS INC | $134.21M | $1.98 | $11.00 | 455.56% | Buy | 5 | -49.09% | 142.34% | N/A | N/A | ||||
| UTHR | UNITED THERAPEUTICS CORP | $11.15B | $236.93 | $298.00 | 25.78% | Strong Buy | 7 | 9.49% | 8.78% | N/A | N/A | ||||
| CORT | CORCEPT THERAPEUTICS INC | $2.35B | $22.66 | $36.00 | 58.87% | Strong Buy | 3 | 16.84% | 29.98% | N/A | N/A | ||||
| EXEL | EXELIXIS INC | $6.82B | $22.49 | $27.17 | 20.80% | Buy | 6 | 8.37% | 55.63% | N/A | N/A | ||||
| PBYI | PUMA BIOTECHNOLOGY INC | $240.55M | $4.99 | $7.00 | 40.28% | Buy | 1 | 0.26% | 31.88% | N/A | N/A | ||||
| MDXG | MIMEDX GROUP INC | $905.26M | $6.16 | $12.67 | 105.63% | Strong Buy | 3 | 11.82% | 25.46% | N/A | N/A | ||||
| HALO | HALOZYME THERAPEUTICS INC | $4.80B | $37.81 | $54.17 | 43.26% | Buy | 6 | 15.99% | 48.53% | N/A | N/A | ||||
| RPRX | ROYALTY PHARMA PLC | $16.66B | $27.89 | $46.75 | 67.62% | Strong Buy | 4 | 11.31% | 34.87% | N/A | N/A | ||||
| ROIV | ROIVANT SCIENCES LTD | $8.35B | $10.36 | $17.11 | 65.16% | Strong Buy | 9 | 77.78% | N/A | N/A | N/A | ||||
| TGTX | TG THERAPEUTICS INC | $2.16B | $13.99 | $30.20 | 115.87% | Strong Buy | 5 | 38.43% | 139.09% | N/A | N/A | ||||
| GMAB | GENMAB A | $18.72B | $28.33 | $45.00 | 58.84% | Buy | 4 | 21.82% | 48.09% | N/A | N/A | ||||
| MEIP | MEI PHARMA INC | $21.65M | $3.25 | $7.00 | 115.38% | Hold | 1 | -42.12% | N/A | N/A | N/A | ||||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $16.99B | $90.07 | $101.30 | 12.47% | Buy | 10 | 12.22% | 94.71% | N/A | N/A | ||||
| BNTX | BIONTECH SE | $20.48B | $86.17 | $114.71 | 33.13% | Hold | 7 | -10.66% | 36.84% | N/A | N/A | ||||
| VNDA | VANDA PHARMACEUTICALS INC | $285.96M | $4.97 | N/A | N/A | N/A | N/A | 13.15% | 102.06% | N/A | N/A | ||||
| DBVT | DBV TECHNOLOGIES SA | $127.48M | $0.66 | $10.00 | 1,412.86% | Buy | 1 | 166.59% | N/A | N/A | N/A | ||||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $82.55M | $1.13 | $10.00 | 784.96% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| SPRO | SPERO THERAPEUTICS INC | $79.19M | $1.47 | $7.00 | 376.19% | Buy | 1 | -31.99% | N/A | N/A | N/A | ||||
| AVRO | AVROBIO INC | $55.63M | $1.24 | $2.00 | 61.29% | Hold | 1 | N/A | N/A | N/A | N/A | ||||
| BNOX | BIONOMICS LIMITED | $11.32M | $0.98 | $8.00 | 716.33% | Buy | 1 | 22,893.66% | N/A | -45,044.89% | -33,660.38% | ||||
| CPRX | CATALYST PHARMACEUTICALS INC | $1.81B | $15.34 | $27.40 | 78.62% | Strong Buy | 5 | 16.34% | 16.52% | N/A | N/A | ||||
| CRSP | CRISPR THERAPEUTICS AG | $4.51B | $56.16 | $84.00 | 49.57% | Buy | 11 | 52.20% | N/A | N/A | N/A | ||||
| KNSA | KINIKSA PHARMACEUTICALS LTD | $1.19B | $16.88 | $25.00 | 48.10% | Buy | 1 | 29.61% | N/A | N/A | N/A | ||||
| TFFP | TFF PHARMACEUTICALS INC | $7.90M | $3.14 | $44.00 | 1,303.51% | Strong Buy | 1 | 136.51% | N/A | N/A | N/A | ||||
| IGMS | IGM BIOSCIENCES INC | $435.61M | $7.41 | $15.67 | 111.43% | Buy | 6 | 250.10% | N/A | N/A | N/A | ||||
| SEER | SEER INC | $113.35M | $1.75 | N/A | N/A | N/A | N/A | 39.00% | N/A | N/A | N/A | ||||
| OCUP | OCUPHIRE PHARMA INC | $41.44M | $1.67 | $20.00 | 1,097.60% | Strong Buy | 2 | 46.92% | N/A | N/A | N/A | ||||
| AXSM | AXSOME THERAPEUTICS INC | $3.11B | $65.72 | $126.80 | 92.94% | Strong Buy | 10 | 50.00% | N/A | N/A | N/A | ||||
| MIRM | MIRUM PHARMACEUTICALS INC | $1.11B | $23.57 | $52.75 | 123.80% | Strong Buy | 8 | 46.25% | N/A | N/A | N/A | ||||
| KRYS | KRYSTAL BIOTECH INC | $4.64B | $163.97 | $182.80 | 11.48% | Strong Buy | 5 | 104.18% | 52.91% | N/A | N/A | ||||
| NVO | NOVO NORDISK A S | $553.60B | $122.75 | $133.00 | 8.35% | Strong Buy | 6 | 20.70% | 4.76% | N/A | N/A | ||||
| FULC | FULCRUM THERAPEUTICS INC | $437.26M | $7.06 | $13.00 | 84.14% | Buy | 4 | 218.27% | N/A | N/A | N/A | ||||
| REGN | REGENERON PHARMACEUTICALS INC | $98.13B | $893.99 | $1.00k | 12.15% | Buy | 16 | 7.34% | 4.84% | N/A | N/A | ||||
| AGIO | AGIOS PHARMACEUTICALS INC | $1.65B | $29.43 | $33.33 | 13.26% | Hold | 3 | 89.47% | N/A | N/A | N/A | ||||
| CLGN | COLLPLANT BIOTECHNOLOGIES LTD | $59.78M | $5.22 | $11.00 | 110.73% | Buy | 1 | 28.53% | N/A | N/A | N/A | ||||
| TECH | BIO-TECHNE CORP | $9.78B | $62.21 | $78.43 | 26.07% | Strong Buy | 7 | 6.84% | 29.33% | N/A | N/A | ||||
| VYNE | VYNE THERAPEUTICS INC | $32.43M | $2.30 | $5.75 | 150.00% | Buy | 1 | 479.50% | N/A | N/A | N/A | ||||
| RNA | AVIDITY BIOSCIENCES INC | $1.84B | $23.04 | $44.50 | 93.14% | Strong Buy | 4 | 178.46% | N/A | N/A | N/A | ||||
| PRTA | PROTHENA CORP PUBLIC LTD CO | $1.11B | $20.57 | $68.14 | 231.27% | Buy | 7 | 34.72% | N/A | N/A | N/A | ||||
| IDYA | IDEAYA BIOSCIENCES INC | $2.80B | $37.62 | $52.14 | 38.60% | Strong Buy | 7 | 46.64% | N/A | N/A | N/A | ||||
| IMMP | IMMUTEP LTD | $261.54M | $2.20 | N/A | N/A | N/A | N/A | 452.47% | N/A | N/A | N/A | ||||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $6.81B | $109.27 | $193.09 | 76.71% | Strong Buy | 11 | 6.52% | 64.32% | N/A | N/A | ||||
| VTGN | VISTAGEN THERAPEUTICS INC | $127.02M | $4.70 | $13.50 | 187.23% | Strong Buy | 2 | 109.58% | N/A | N/A | N/A | ||||
| MDWD | MEDIWOUND LTD | $156.68M | $16.99 | $28.00 | 64.80% | Buy | 1 | 39.36% | N/A | N/A | N/A | ||||
| GNFT | GENFIT SA | $178.91M | $3.59 | $11.00 | 206.41% | Buy | 1 | 23.22% | N/A | N/A | N/A | ||||
| ADAG | ADAGENE INC | $116.47M | $2.64 | N/A | N/A | N/A | N/A | 37.92% | N/A | N/A | N/A | ||||
| ORMP | ORAMED PHARMACEUTICALS INC | $89.14M | $2.20 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC | $708.41M | $26.32 | $63.25 | 140.31% | Strong Buy | 4 | 78.10% | N/A | N/A | N/A | ||||
| LPCN | LIPOCINE INC | $28.92M | $5.44 | N/A | N/A | N/A | N/A | N/A | N/A | 39.93% | 35.36% | ||||
| INM | INMED PHARMACEUTICALS INC | $1.82M | $0.30 | N/A | N/A | N/A | N/A | 78.42% | N/A | -237.12% | -198.52% | ||||
| KZR | KEZAR LIFE SCIENCES INC | $57.37M | $0.79 | $11.00 | 1,295.94% | Buy | 2 | 47.18% | N/A | N/A | N/A | ||||
| ALGS | ALIGOS THERAPEUTICS INC | $60.01M | $0.79 | N/A | N/A | N/A | N/A | 235.91% | N/A | N/A | N/A | ||||
| ZLAB | ZAI LAB LTD | $1.41B | $14.22 | $63.21 | 344.51% | Strong Buy | 4 | 46.92% | N/A | N/A | N/A | ||||
| XCUR | EXICURE INC | $5.01M | $0.58 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| GBIO | GENERATION BIO CO | $184.81M | $2.78 | $7.50 | 169.78% | Buy | 2 | 16.09% | N/A | N/A | N/A | ||||
| ANIX | ANIXA BIOSCIENCES INC | $98.89M | $3.10 | $12.00 | 287.10% | Buy | 1 | 1,188.83% | N/A | N/A | N/A | ||||
| SAGE | SAGE THERAPEUTICS INC | $783.49M | $13.04 | $21.46 | 64.60% | Hold | 11 | 49.36% | N/A | N/A | N/A | ||||
| LEGN | LEGEND BIOTECH CORP | $8.57B | $47.12 | $82.86 | 75.84% | Strong Buy | 7 | 85.32% | N/A | N/A | N/A | ||||
| QURE | UNIQURE NV | $225.32M | $4.71 | $17.80 | 277.92% | Buy | 5 | 76.45% | N/A | N/A | N/A | ||||
| MORF | MORPHIC HOLDING INC | $1.38B | $27.51 | $56.00 | 103.56% | Strong Buy | 2 | 441.99% | N/A | N/A | N/A | ||||
| GLPG | GALAPAGOS NV | $1.91B | $28.91 | $34.50 | 19.34% | Sell | 2 | 6.93% | N/A | N/A | N/A | ||||
| PTGX | PROTAGONIST THERAPEUTICS INC | $1.47B | $25.22 | $39.00 | 54.64% | Strong Buy | 3 | 34.38% | N/A | N/A | N/A | ||||
| LIFE | ATYR PHARMA INC | $109.76M | $1.62 | $25.50 | 1,474.07% | Buy | 2 | 531.56% | N/A | N/A | N/A | ||||
| BOLT | BOLT BIOTHERAPEUTICS INC | $43.47M | $1.14 | $8.00 | 601.75% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| MRUS | MERUS NV | $2.34B | $40.47 | $61.33 | 51.55% | Strong Buy | 6 | 45.96% | N/A | N/A | N/A | ||||
| SNSE | SENSEI BIOTHERAPEUTICS INC | $24.64M | $0.98 | $4.00 | 306.92% | Buy | 1 | N/A | N/A | N/A | N/A | ||||
| ACIU | AC IMMUNE SA | $236.09M | $2.38 | $16.00 | 572.27% | Buy | 1 | 89.78% | N/A | N/A | N/A | ||||
| FATE | FATE THERAPEUTICS INC | $500.16M | $5.04 | $7.13 | 41.37% | Hold | 8 | 92.56% | N/A | N/A | N/A | ||||
| SLGL | SOL-GEL TECHNOLOGIES LTD | $25.07M | $0.90 | $9.00 | 900.00% | Buy | 1 | 75.66% | N/A | N/A | N/A | ||||
| ABIO | ARCA BIOPHARMA INC | $47.13M | $3.25 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| XBIO | XENETIC BIOSCIENCES INC | $6.38M | $4.14 | N/A | N/A | N/A | N/A | -6.64% | N/A | N/A | N/A | ||||
| ARGX | ARGENX SE | $21.22B | $358.41 | $511.67 | 42.76% | Strong Buy | 15 | 339.06% | N/A | N/A | N/A | ||||
| FUSN | FUSION PHARMACEUTICALS INC | $1.80B | $21.25 | $20.25 | -4.71% | Hold | 8 | 96.93% | N/A | N/A | N/A | ||||
| NRBO | NEUROBO PHARMACEUTICALS INC | $16.88M | $3.44 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| CDTX | CIDARA THERAPEUTICS INC | $65.29M | $0.72 | $6.00 | 731.02% | Buy | 1 | 35.78% | N/A | N/A | N/A | ||||
| BCYC | BICYCLE THERAPEUTICS PLC | $1.04B | $24.49 | $49.17 | 100.76% | Buy | 6 | 14.15% | N/A | N/A | N/A | ||||
| MRKR | MARKER THERAPEUTICS INC | $36.50M | $4.10 | N/A | N/A | N/A | N/A | 272.67% | N/A | N/A | N/A | ||||
| CLNN | CLENE INC | $42.38M | $0.33 | $6.00 | 1,718.18% | Strong Buy | 2 | 103.75% | N/A | N/A | N/A | ||||
| ZVRA | ZEVRA THERAPEUTICS INC | $195.42M | $4.50 | $15.00 | 233.33% | Buy | 1 | 92.47% | N/A | N/A | N/A | ||||
| EDIT | EDITAS MEDICINE INC | $454.07M | $5.55 | $14.00 | 152.25% | Buy | 4 | 9.55% | N/A | N/A | N/A | ||||
| TRAW | TRAWS PHARMA INC | $14.64M | $0.70 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| JANX | JANUX THERAPEUTICS INC | $2.52B | $48.85 | $58.14 | 19.02% | Strong Buy | 7 | 131.99% | N/A | N/A | N/A | ||||
| VERV | VERVE THERAPEUTICS INC | $556.90M | $6.66 | $37.50 | 463.06% | Strong Buy | 2 | 16.20% | N/A | N/A | N/A | ||||
| ALT | ALTIMMUNE INC | $488.47M | $6.89 | $15.00 | 117.71% | Buy | 3 | 313.34% | N/A | N/A | N/A | ||||
| ARDX | ARDELYX INC | $1.50B | $6.44 | $13.83 | 114.80% | Strong Buy | 6 | 66.03% | N/A | N/A | N/A | ||||
| EYPT | EYEPOINT PHARMACEUTICALS INC | $872.04M | $17.50 | $37.75 | 115.71% | Strong Buy | 4 | N/A | N/A | N/A | N/A | ||||
| RYTM | RHYTHM PHARMACEUTICALS INC | $2.29B | $38.11 | $52.25 | 37.10% | Strong Buy | 4 | 64.76% | N/A | N/A | N/A | ||||
| ZYME | ZYMEWORKS INC | $611.83M | $8.67 | $12.00 | 38.41% | Buy | 2 | 25.27% | N/A | N/A | N/A | ||||
| BGNE | BEIGENE LTD | $13.81B | $131.96 | $244.25 | 85.09% | Strong Buy | 4 | 26.07% | N/A | N/A | N/A | ||||
| PLRX | PLIANT THERAPEUTICS INC | $734.32M | $12.19 | $46.67 | 282.83% | Buy | 3 | 45.40% | N/A | N/A | N/A | ||||
| SRPT | SAREPTA THERAPEUTICS INC | $10.94B | $116.55 | $155.54 | 33.45% | Strong Buy | 13 | 40.58% | N/A | N/A | N/A | ||||
| SPRY | ARS PHARMACEUTICALS INC | $814.47M | $8.44 | $18.50 | 119.19% | Buy | 2 | 1,785.77% | N/A | N/A | N/A | ||||
| ITOS | ITEOS THERAPEUTICS INC | $370.26M | $10.33 | $33.33 | 222.68% | Strong Buy | 3 | 120.33% | N/A | N/A | N/A | ||||
| RVMD | REVOLUTION MEDICINES INC | $5.90B | $35.83 | $41.10 | 14.71% | Strong Buy | 10 | 47.70% | N/A | N/A | N/A | ||||
| VRTX | VERTEX PHARMACEUTICALS INC | $101.64B | $393.48 | $451.75 | 14.81% | Buy | 16 | 8.93% | 2.45% | N/A | N/A | ||||
| SPRB | SPRUCE BIOSCIENCES INC | $28.85M | $0.70 | $5.40 | 670.33% | Buy | 5 | 84.64% | N/A | N/A | N/A | ||||
| OCS | OCULIS HOLDING AG | $431.73M | $11.78 | $30.75 | 161.04% | Strong Buy | 4 | 199.71% | N/A | N/A | N/A |
Biotech Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.